{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:50:18Z","timestamp":1790884218697,"version":"4.1.0"},"reference-count":69,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"abstract":"<jats:p>Hydroxyurea, blood transfusions, and hematopoietic stem cell transplantation represent the 3 disease-modifying therapies in children with sickle cell disease (SCD). Blood transfusions play an increasingly important role in both prevention and management of SCD complications in this age group. This review will focus on the indications of blood transfusion in children with SCD and modalities of its administration. It will also highlight the complications of this life-saving therapy and ways of optimizing transfusion to minimize its associated risks.<\/jats:p>","DOI":"10.1097\/mph.0000000000000645","type":"journal-article","created":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T12:39:30Z","timestamp":1470746370000},"page":"126-132","source":"Crossref","is-referenced-by-count":15,"title":["Transfusion Therapy in Children With Sickle Cell Disease"],"prefix":"10.1097","volume":"39","author":[{"given":"Adlette","family":"Inati","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Lebanese American University and University Medical Center Rizk Hospital, Beirut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony G.","family":"Mansour","sequence":"additional","affiliation":[{"name":"School of Medicine, Lebanese American University, Byblos, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni","family":"Sabbouh","sequence":"additional","affiliation":[{"name":"School of Medicine, Lebanese American University, Byblos, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghid","family":"Amhez","sequence":"additional","affiliation":[{"name":"School of Medicine, Lebanese American University, Byblos, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Hachem","sequence":"additional","affiliation":[{"name":"School of Medicine, Lebanese American University, Byblos, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein A.","family":"Abbas","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0140-6736(04)17192-4","article-title":"Sickle-cell disease","volume":"364","author":"Stuart","year":"2004","journal-title":"Lancet"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"949535","DOI":"10.1100\/2012\/949535","article-title":"Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management","volume":"2012","author":"Ballas","year":"2012","journal-title":"ScientificWorldJournal"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/pbc.22721","article-title":"Iron in sickle-cell disease: what have we learned over the years?","volume":"56","author":"Inati","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"R5-20230918","first-page":"2769","article-title":"Optimizing primary stroke prevention in sickle cell anemia (STOP II) Trial Investigators","volume":"353","author":"Adam","year":"2005","journal-title":"N Engl J Med"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0197-2456(97)00099-8","article-title":"Stroke prevention trial in sickle cell anemia","volume":"19","author":"Adams","year":"1998","journal-title":"Control Clin Trials"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"N Engl J Med"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0022-3476(05)82006-2","article-title":"Effects of a long-term transfusion regimen on sickle cell-related illnesses","volume":"125","author":"Styles","year":"1994","journal-title":"J Pediatr"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3109\/03630269.2011.596984","article-title":"Blood transfusion in sickle cell disease","volume":"35","author":"Marouf","year":"2011","journal-title":"Hemoglobin"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1182\/asheducation-2006.1.48","article-title":"Red cell exchange in sickle cell disease","volume":"2006","author":"Swerdlow","year":"2006","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1046\/j.1537-2995.2001.41050596.x","article-title":"RBC transfusion in sickle cell anemia (HbSS): experience from the Jamaican Cohort Study","volume":"41","author":"Thame","year":"2001","journal-title":"Transfusion"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJM199904013401307","article-title":"Management of sickle cell disease","volume":"340","author":"Wood","year":"1999","journal-title":"N Engl J Med"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/pbc.24179","article-title":"Indications and complications of transfusions in sickle cell disease","volume":"59","author":"Smith-Whitley","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1056\/NEJMoa050460","article-title":"Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease","volume":"353","author":"Adams","year":"2005","journal-title":"N Engl J Med"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0022-3476(05)82150-X","article-title":"High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease","volume":"118","author":"Wang","year":"1991","journal-title":"J Pediatr"},{"issue":"suppl 1","key":"R16-20230918","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0037-1963(01)90056-3","article-title":"Current issues with blood transfusions in sickle cell disease","volume":"38","author":"Vichinsky","year":"2001","journal-title":"Semin Hematol"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1182\/blood.V81.5.1109.bloodjournal8151109","article-title":"Transfusion management of sickle cell disease","volume":"81","author":"Wayne","year":"1993","journal-title":"Blood"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1365-2141.2011.08999.x","article-title":"Acute splenic sequestration crisis in sickle cell disease: cohort study of 190 paediatric patients","volume":"156","author":"Brousse","year":"2012","journal-title":"Br J Haematol"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/adc.56.10.765","article-title":"Acute splenic sequestration and hypersplenism in the first five years in homozygous sickle cell disease","volume":"56","author":"Topley","year":"1981","journal-title":"Arch Dis Child"},{"key":"R20-20230918","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1182\/blood-2003-01-0069","article-title":"Epidemiology of human parvovirus B19 in children with sickle cell disease","volume":"103","author":"Smith-Whitley","year":"2004","journal-title":"Blood"},{"key":"R21-20230918","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3928\/00904481-20130222-11","article-title":"A review of acute chest syndrome in pediatric sickle cell disease","volume":"42","author":"Abbas","year":"2013","journal-title":"Pediatr Ann"},{"key":"R22-20230918","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.1182\/blood-2010-11-261834","article-title":"How I treat acute chest syndrome in children with sickle cell disease","volume":"117","author":"Miller","year":"2011","journal-title":"Blood"},{"key":"R23-20230918","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/pbc.22211","article-title":"Erythrocytapheresis in children with sickle cell disease and acute chest syndrome","volume":"53","author":"Velasquez","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"R24-20230918","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJM200001133420203","article-title":"Prediction of adverse outcomes in children with sickle cell disease","volume":"342","author":"Miller","year":"2000","journal-title":"N Engl J Med"},{"key":"R25-20230918","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jpeds.2006.06.037","article-title":"Exchange blood transfusion compared with simple transfusion for first overt stroke is associated with a lower risk of subsequent stroke: a retrospective cohort study of 137 children with sickle cell anemia","volume":"149","author":"Hulbert","year":"2006","journal-title":"J Pediatr"},{"key":"R26-20230918","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1182\/blood.V86.10.3676.bloodjournal86103676","article-title":"Surgery and anesthesia in sickle cell disease. Cooperative Study of Sickle Cell Diseases","volume":"86","author":"Koshy","year":"1995","journal-title":"Blood"},{"key":"R27-20230918","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1056\/NEJM199507273330402","article-title":"A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease","volume":"333","author":"Vichinsky","year":"1995","journal-title":"N Engl J Med"},{"key":"R28-20230918","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0140-6736(12)61726-7","article-title":"The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trial","volume":"381","author":"Howard","year":"2013","journal-title":"Lancet"},{"key":"R29-20230918","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1182\/blood-2010-06-293514","article-title":"Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort","volume":"117","author":"Bernaudin","year":"2011","journal-title":"Blood"},{"key":"R30-20230918","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/STR.0b013e3181fcb238","article-title":"Guidelines for the primary prevention of stroke a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Goldstein","year":"2011","journal-title":"Stroke"},{"key":"R31-20230918","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(15)01041-7","article-title":"Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial","volume":"387","author":"Ware","year":"2016","journal-title":"Lancet"},{"key":"R32-20230918","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0022-3476(95)70204-0","article-title":"Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions","volume":"126","author":"Pegelow","year":"1995","journal-title":"J Pediatr"},{"key":"R33-20230918","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood-2011-11-392340","article-title":"Stroke with transfusions changing to hydroxyurea (SWiTCH)","volume":"119","author":"Ware","year":"2012","journal-title":"Blood"},{"key":"R34-20230918","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1172\/JCI30920","article-title":"Sickle cell disease: old discoveries, new concepts, and future promise","volume":"117","author":"Frenette","year":"2007","journal-title":"J Clin Invest"},{"key":"R35-20230918","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1067\/mpd.2001.119593","article-title":"Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia","volume":"139","author":"Miller","year":"2001","journal-title":"J Pediatr"},{"key":"R36-20230918","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1182\/blood-2008-07-077370","article-title":"The hazards of blood transfusion in historical perspective","volume":"112","author":"Alter","year":"2008","journal-title":"Blood"},{"key":"R37-20230918","first-page":"521","article-title":"Prevalence of Rh, Duffy, Kell, Kidd & MNSs blood group antigens in the Indian blood donor population","volume":"137","author":"Makroo","year":"2013","journal-title":"Indian J Med Res"},{"key":"R38-20230918","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2141.2011.08720.x","article-title":"Long-term safety and efficacy of deferasirox (Exjade\u00ae) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease","volume":"154","author":"Vichinsky","year":"2011","journal-title":"Br J Haematol"},{"key":"R39-20230918","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1423-0410.2005.00648.x","article-title":"Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion","volume":"89","author":"Bux","year":"2005","journal-title":"Vox Sang"},{"key":"R40-20230918","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.resuscitation.2008.02.001","article-title":"Emergency treatment of anaphylactic reactions\u2014guidelines for healthcare providers","volume":"77","author":"Soar","year":"2008","journal-title":"Resuscitation"},{"key":"R41-20230918","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/ajh.23105","article-title":"Chronic transfusion practices for prevention of primary stroke in children with sickle cell anemia and abnormal TCD velocities","volume":"87","author":"Aygun","year":"2012","journal-title":"Am J Hematol"},{"key":"R42-20230918","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJM199006073222301","article-title":"Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood","volume":"322","author":"Vichinsky","year":"1990","journal-title":"N Engl J Med"},{"key":"R43-20230918","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1182\/blood.V76.7.1431.1431","article-title":"Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease","volume":"76","author":"Rosse","year":"1990","journal-title":"Blood"},{"key":"R44-20230918","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/bjh.13494","article-title":"How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease","volume":"170","author":"Gardner","year":"2015","journal-title":"Br J Haematol"},{"key":"R45-20230918","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/bjh.13123","article-title":"Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease","volume":"168","author":"Fasano","year":"2015","journal-title":"Br J Haematol"},{"key":"R46-20230918","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/trf.12987","article-title":"Changing practice: red blood cell typing by molecular methods for patients with sickle cell disease","volume":"55","author":"Casas","year":"2015","journal-title":"Transfusion"},{"key":"R47-20230918","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1537-2995.2002.00007.x","article-title":"Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions","volume":"42","author":"Aygun","year":"2002","journal-title":"Transfusion"},{"issue":"suppl 1","key":"R48-20230918","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0037-1963(01)90057-5","article-title":"Techniques for blood administration in sickle cell patients","volume":"38","author":"Eckman","year":"2001","journal-title":"Semin Hematol"},{"key":"R49-20230918","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1537-2995.1982.22182154208.x","article-title":"Effects of transfusion on rheological properties of blood in sickle cell anemia","volume":"22","author":"Jan","year":"1982","journal-title":"Transfusion"},{"key":"R50-20230918","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.1537-2995.1987.27387235626.x","article-title":"Viscosity of mixtures of sickle and normal red cells at varying hematocrit levels. Implications for transfusion","volume":"27","author":"Schmalzer","year":"1987","journal-title":"Transfusion"},{"key":"R51-20230918","first-page":"e22","article-title":"Best practices for transfusion for patients with sickle cell disease","volume":"1","author":"Wun","year":"2009","journal-title":"Hematol Rev"},{"key":"R52-20230918","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/ajh.20809","article-title":"Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: a report from the multi-center study of iron overload","volume":"82","author":"Fung","year":"2007","journal-title":"Am J Hematol"},{"key":"R53-20230918","first-page":"51","article-title":"Patterns of liver iron accumulation in patients with sickle cell disease and thalassemia with iron overload","volume":"85","author":"Hankins","year":"2010","journal-title":"Eur J Haematol"},{"key":"R54-20230918","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1365-2141.2001.03195.x","article-title":"Practical management of iron overload","volume":"115","author":"Porter","year":"2001","journal-title":"Br J Haematol"},{"key":"R55-20230918","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMe1405776","article-title":"More blood for sickle cell anemia?","volume":"371","author":"Steinberg","year":"2014","journal-title":"N Engl J Med"},{"key":"R56-20230918","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3324\/haematol.2009.014696","article-title":"Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias","volume":"95","author":"Cappellini","year":"2010","journal-title":"Haematologica"},{"key":"R57-20230918","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2141.2011.08769.x","article-title":"Chelation treatment in sickle-cell-anaemia: much ado about nothing?","volume":"154","author":"Lucania","year":"2011","journal-title":"Br J Haematol"},{"key":"R58-20230918","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1182\/asheducation-2013.1.447","article-title":"Consequences and management of iron overload in sickle cell disease","volume":"2013","author":"Porter","year":"2013","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R59-20230918","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/ajh.20402","article-title":"Comparison of organ dysfunction in transfused patients with SCD or \u03b2 thalassemia","volume":"80","author":"Vichinsky","year":"2005","journal-title":"Am J Hematol"},{"key":"R60-20230918","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/bjh.13339","article-title":"Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience","volume":"169","author":"Vidler","year":"2015","journal-title":"Br J Haematol"},{"key":"R61-20230918","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S1246-7820(01)00113-6","article-title":"Mechanisms of severe transfusion reactions","volume":"8","author":"Kopko","year":"2001","journal-title":"Transfus Clin Biol"},{"key":"R62-20230918","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1537-2995.2007.01269.x","article-title":"Bacterial infections associated with blood transfusion: experience and perspective of infectious diseases consultants","volume":"47","author":"Rao","year":"2007","journal-title":"Transfusion"},{"key":"R63-20230918","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/S0140-6736(04)17194-8","article-title":"Attributable testing for abnormal prion protein, database linkage, and blood-borne vCJD risks","volume":"364","author":"Bird","year":"2004","journal-title":"Lancet"},{"key":"R64-20230918","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/bja\/69.6.621","article-title":"Massive blood transfusion","volume":"69","author":"Donaldson","year":"1992","journal-title":"Br J Anaesth"},{"key":"R65-20230918","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0887-7963(88)70035-8","article-title":"Citrate toxicity during massive blood transfusion","volume":"2","author":"Dzik","year":"1988","journal-title":"Transfus Med Rev"},{"key":"R66-20230918","first-page":"581","article-title":"The cardiovascular effects of low levels of ionized calcium during massive transfusion","volume":"145","author":"Howland","year":"1977","journal-title":"Surg Gynecol Obstet"},{"key":"R67-20230918","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1213\/ane.0b013e318164f03d","article-title":"Cardiac arrests associated with hyperkalemia during red blood cell transfusion: a case series","volume":"106","author":"Smith","year":"2008","journal-title":"Anesth Analg"},{"key":"R68-20230918","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/00325481.1971.11696651","article-title":"The potassium load from blood transfusion","volume":"49","author":"Simon","year":"1971","journal-title":"Postgrad Med"},{"key":"R69-20230918","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1401731","article-title":"Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia","volume":"371","author":"DeBaun","year":"2014","journal-title":"N Engl J Med"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201703000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T01:52:59Z","timestamp":1695001979000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201703000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000645","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]}}}